Academic Journal
Deciphering the significance of p53 mutant proteins.
| Title: | Deciphering the significance of p53 mutant proteins. |
|---|---|
| Authors: | Butera A; Chair of Systems Toxicology, University of Konstanz, Konstanz, Germany., Amelio I; Chair of Systems Toxicology, University of Konstanz, Konstanz, Germany. Electronic address: ivano.amelio@uni-konstanz.de. |
| Source: | Trends in cell biology [Trends Cell Biol] 2025 Mar; Vol. 35 (3), pp. 258-268. Date of Electronic Publication: 2024 Jul 02. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: England NLM ID: 9200566 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3088 (Electronic) Linking ISSN: 09628924 NLM ISO Abbreviation: Trends Cell Biol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Cambridge, UK : Elsevier Science Publishers, c1991- |
| MeSH Terms: | Tumor Suppressor Protein p53*/genetics , Tumor Suppressor Protein p53*/metabolism , Mutation*/genetics , Neoplasms*/genetics , Neoplasms*/metabolism , Neoplasms*/pathology , Mutant Proteins*/genetics , Mutant Proteins*/metabolism, Humans ; Animals |
| Abstract: | Mutations in the p53 gene compromise its role as guardian of genomic integrity, yielding predominantly missense p53 mutant proteins. The gain-of-function hypothesis has long suggested that these mutant proteins acquire new oncogenic properties; however, recent studies challenge this notion, indicating that targeting these mutants may not impact the fitness of cancer cells. Mounting evidence indicates that tumorigenesis involves a cooperative interplay between driver mutations and cellular state, influenced by developmental stage, external insults, and tissue damage. Consistently, the behavior and properties of p53 mutants are altered by the context. This article aims to provide a balanced summary of the evolving evidence regarding the contribution of p53 mutants in the biology of cancer while contemplating alternative frameworks to decipher the complexity of p53 mutants within their physiological contexts. (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.) |
| Competing Interests: | Declaration of interests The authors declare that they have no competing interests. |
| Comments: | Erratum in: Trends Cell Biol. 2026 Apr 1:S0962-8924(26)00002-4. doi: 10.1016/j.tcb.2026.01.002.. (PMID: 41927354) |
| Contributed Indexing: | Keywords: cancer; context-dependent; dominant-negative; gain-of-function; microenvironment |
| Substance Nomenclature: | 0 (Tumor Suppressor Protein p53) 0 (Mutant Proteins) |
| Entry Date(s): | Date Created: 20240703 Date Completed: 20250422 Latest Revision: 20260402 |
| Update Code: | 20260403 |
| DOI: | 10.1016/j.tcb.2024.06.003 |
| PMID: | 38960851 |
| Database: | MEDLINE |
| FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=4168B792413A8ABFF285&Show=Object Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.tcb.2024.06.003? Name: ScienceDirect (all content) (s7799221) Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 38960851 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Deciphering the significance of p53 mutant proteins. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Butera+A%22">Butera A</searchLink>; Chair of Systems Toxicology, University of Konstanz, Konstanz, Germany.<br /><searchLink fieldCode="AU" term="%22Amelio+I%22">Amelio I</searchLink>; Chair of Systems Toxicology, University of Konstanz, Konstanz, Germany. Electronic address: ivano.amelio@uni-konstanz.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229200566%22">Trends in cell biology</searchLink> [Trends Cell Biol] 2025 Mar; Vol. 35 (3), pp. 258-268. <i>Date of Electronic Publication: </i>2024 Jul 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9200566 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-3088 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209628924%22">09628924 </searchLink><i>NLM ISO Abbreviation: </i>Trends Cell Biol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Cambridge, UK : Elsevier Science Publishers, c1991- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Tumor+Suppressor+Protein+p53%22">Tumor Suppressor Protein p53*</searchLink>/<searchLink fieldCode="MM" term="%22Tumor+Suppressor+Protein+p53+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Tumor+Suppressor+Protein+p53%22">Tumor Suppressor Protein p53*</searchLink>/<searchLink fieldCode="MM" term="%22Tumor+Suppressor+Protein+p53+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutation%22">Mutation*</searchLink>/<searchLink fieldCode="MM" term="%22Mutation+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Neoplasms%22">Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Neoplasms+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Neoplasms%22">Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Neoplasms+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Neoplasms%22">Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Neoplasms+pathology%22">pathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutant+Proteins%22">Mutant Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Mutant+Proteins+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutant+Proteins%22">Mutant Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Mutant+Proteins+metabolism%22">metabolism</searchLink><br /><searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Mutations in the p53 gene compromise its role as guardian of genomic integrity, yielding predominantly missense p53 mutant proteins. The gain-of-function hypothesis has long suggested that these mutant proteins acquire new oncogenic properties; however, recent studies challenge this notion, indicating that targeting these mutants may not impact the fitness of cancer cells. Mounting evidence indicates that tumorigenesis involves a cooperative interplay between driver mutations and cellular state, influenced by developmental stage, external insults, and tissue damage. Consistently, the behavior and properties of p53 mutants are altered by the context. This article aims to provide a balanced summary of the evolving evidence regarding the contribution of p53 mutants in the biology of cancer while contemplating alternative frameworks to decipher the complexity of p53 mutants within their physiological contexts.<br /> (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.) – Name: Abstract Label: Competing Interests Group: Ab Data: Declaration of interests The authors declare that they have no competing interests. – Name: Comment Label: Comments Group: Commnt Data: Erratum in: Trends Cell Biol. 2026 Apr 1:S0962-8924(26)00002-4. doi: 10.1016/j.tcb.2026.01.002.. (PMID: <searchLink fieldCode="PM" term="%2241927354%22">41927354)</searchLink> – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>cancer; context-dependent; dominant-negative; gain-of-function; microenvironment – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Tumor Suppressor Protein p53)<br />0 (Mutant Proteins) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20240703 <i>Date Completed: </i>20250422 <i>Latest Revision: </i>20260402 – Name: DateUpdate Label: Update Code Group: Date Data: 20260403 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.tcb.2024.06.003 – Name: AN Label: PMID Group: ID Data: 38960851 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=38960851 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.tcb.2024.06.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 258 Subjects: – SubjectFull: Humans Type: general – SubjectFull: Animals Type: general – SubjectFull: Tumor Suppressor Protein p53 genetics Type: general – SubjectFull: Tumor Suppressor Protein p53 metabolism Type: general – SubjectFull: Mutation genetics Type: general – SubjectFull: Neoplasms genetics Type: general – SubjectFull: Neoplasms metabolism Type: general – SubjectFull: Neoplasms pathology Type: general – SubjectFull: Mutant Proteins genetics Type: general – SubjectFull: Mutant Proteins metabolism Type: general Titles: – TitleFull: Deciphering the significance of p53 mutant proteins. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Butera A – PersonEntity: Name: NameFull: Amelio I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-3088 Numbering: – Type: volume Value: 35 – Type: issue Value: 3 Titles: – TitleFull: Trends in cell biology Type: main |
| ResultId | 1 |